Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D3E9 | ISIN: US76090R2004 | Ticker-Symbol: 24O0
NASDAQ
17.05.24
21:48 Uhr
0,176 US-Dollar
+0,006
+3,23 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
RESHAPE LIFESCIENCES INC Chart 1 Jahr
5-Tage-Chart
RESHAPE LIFESCIENCES INC 5-Tage-Chart

Aktuelle News zur RESHAPE LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:26ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2024 Earnings Call Transcript1
DoReShape Lifesciences Inc reports results for the quarter ended in March - Earnings Summary1
MiReShape Lifesciences Inc. - 10-Q, Quarterly Report1
MiReShape Lifesciences Inc: ReShape Lifesciences Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update43Commercial Launch of Next-Generation Lap-Band® 2.0 FLEX Continues Significant Reduction in Overall Operating Expenses of 51% in the First Quarter of 2024 Compared to the First Quarter of 2023 Implementation...
► Artikel lesen
DiReShape Lifesciences Inc: ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update2
09.05.ReShape Lifesciences files to sell 11.7M common shares for holders2
04.04.ReShape Lifesciences Inc. - 8-K, Current Report2
01.04.ReShape Lifesciences Inc. - 10-K, Annual Report1
01.04.ReShape Lifesciences Inc: ReShape Lifesciences Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update93Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference...
► Artikel lesen
28.03.ReShape Lifesciences gets notice of allowance for additional U.S. patent1
28.03.ReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System128IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company...
► Artikel lesen
04.03.ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan2
04.03.ReShape Lifesciences Inc: ReShape Lifesciences Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band 2.0 FLEX1172024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for Synergistic M&A Partner Continues IRVINE, Calif.,...
► Artikel lesen
22.02.ReShape Lifesciences Inc: ReShape Lifesciences Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 FLEX216FLEX Technology Designed to Enhance the Patient Experience Surgeon Training Underway for the Initial Launch of the Lap-Band® 2.0 FLEX IRVINE, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences®...
► Artikel lesen
13.02.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 44.403The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS42328V8019 HELIUS...
► Artikel lesen
24.01.ReShape Lifesciences Inc: ReShape Lifesciences Conducts Bariatric Fellows Training for its Lap-Band System, Highlighting the Next-Generation Lap-Band 2.0 FLEX212IRVINE, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that bariatric...
► Artikel lesen
18.01.ReShape Lifesciences Inc. - 8-K, Current Report4
20.12.23ReShape Lifesciences Inc: ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives1
13.12.23US STOCKS Xpeng, Canopy Growth, ReShape Lifesciences58
13.12.23Why ReShape Lifesciences Stock Is Ripping Higher2
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1